BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $269,000 | -97.1% | 4,194 | -96.5% | 0.00% | -96.9% |
| Q1 2022 | $9,185,000 | -2.7% | 118,456 | +7.7% | 0.13% | -4.5% |
| Q4 2021 | $9,439,000 | +8.6% | 109,967 | +1.7% | 0.13% | -2.9% |
| Q3 2021 | $8,693,000 | +0.6% | 108,080 | +0.7% | 0.14% | -2.1% |
| Q2 2021 | $8,642,000 | -4.1% | 107,346 | +0.5% | 0.14% | -12.5% |
| Q1 2021 | $9,011,000 | +3.2% | 106,847 | -1.8% | 0.16% | -0.6% |
| Q4 2020 | $8,730,000 | +1.1% | 108,808 | +1.3% | 0.16% | -8.0% |
| Q3 2020 | $8,638,000 | -7.2% | 107,416 | -0.6% | 0.18% | -14.6% |
| Q2 2020 | $9,308,000 | -12.9% | 108,112 | -17.9% | 0.20% | -21.8% |
| Q1 2020 | $10,688,000 | -28.9% | 131,644 | -26.8% | 0.26% | -7.1% |
| Q4 2019 | $15,033,000 | -48.0% | 179,777 | -45.6% | 0.28% | -51.3% |
| Q3 2019 | $28,884,000 | +9.0% | 330,212 | +2.0% | 0.58% | +6.4% |
| Q2 2019 | $26,503,000 | +0.5% | 323,607 | -0.2% | 0.54% | -3.7% |
| Q1 2019 | $26,362,000 | +29.3% | 324,217 | +4.7% | 0.56% | +14.8% |
| Q4 2018 | $20,382,000 | -18.7% | 309,664 | -4.8% | 0.49% | -6.1% |
| Q3 2018 | $25,085,000 | +10.9% | 325,399 | +6.2% | 0.52% | +6.5% |
| Q2 2018 | $22,618,000 | +13.4% | 306,312 | -0.1% | 0.49% | +11.1% |
| Q1 2018 | $19,950,000 | +1.0% | 306,730 | +0.4% | 0.44% | +3.0% |
| Q4 2017 | $19,745,000 | +3.0% | 305,464 | +0.0% | 0.43% | -4.2% |
| Q3 2017 | $19,163,000 | +40.3% | 305,394 | +35.3% | 0.45% | +32.8% |
| Q2 2017 | $13,662,000 | +13.5% | 225,669 | -2.8% | 0.34% | +10.5% |
| Q1 2017 | $12,041,000 | +16.1% | 232,184 | -0.8% | 0.31% | +2.7% |
| Q4 2016 | $10,373,000 | +8.7% | 233,946 | +16.6% | 0.30% | +10.4% |
| Q3 2016 | $9,546,000 | +111.5% | 200,555 | +100.9% | 0.27% | +95.7% |
| Q2 2016 | $4,514,000 | – | 99,823 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |